Clinical trial
A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema
NCT00369863 is registered in ClinicalTrials.gov with Shahid Beheshti University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema
- Lead sponsor
- Shahid Beheshti University of Medical Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- June 30, 2003
- Enrollment
- 76
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema